These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 10913933

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
    Ursu HI, Dumitriu L, Grigorie D, Simescu M, Vaida E, Belgun M, Popovici D.
    Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
    [Abstract] [Full Text] [Related]

  • 3. Graves' ophthalmopathy and 131I therapy.
    Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A.
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism.
    Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Pinchera A.
    Thyroid; 1992 Dec; 2(2):171-8. PubMed ID: 1525588
    [Abstract] [Full Text] [Related]

  • 6. Radioiodine therapy and thyroid-associated orbitopathy: risk factors and preventive effects of glucocorticoids.
    Dietlein M, Dederichs B, Weigand A, Schicha H.
    Exp Clin Endocrinol Diabetes; 1999 Dec; 107 Suppl 5():S190-4. PubMed ID: 10614920
    [Abstract] [Full Text] [Related]

  • 7. Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine.
    Barth A, Probst P, Bürgi H.
    J Endocrinol Invest; 1991 Mar; 14(3):209-12. PubMed ID: 2071823
    [Abstract] [Full Text] [Related]

  • 8. Development of Graves' ophthalmopathy and uveitis after radioiodine therapy for Graves' disease in a patient with HTLV-I associated myelopathy (HAM).
    Ozawa Y, Migita M, Watanabe T, Okuda I, Takeshita A, Takagi A, Shishiba Y.
    Intern Med; 1994 Sep; 33(9):564-8. PubMed ID: 8000111
    [Abstract] [Full Text] [Related]

  • 9. Radioiodine therapy and Graves' ophthalmopathy.
    Bartalena L, Marcocci C.
    Thyroid; 1996 Jun; 6(3):253. PubMed ID: 8837336
    [No Abstract] [Full Text] [Related]

  • 10. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.
    Träisk F, Tallstedt L, Abraham-Nordling M, Andersson T, Berg G, Calissendorff J, Hallengren B, Hedner P, Lantz M, Nyström E, Ponjavic V, Taube A, Törring O, Wallin G, Asman P, Lundell G, Thyroid Study Group of TT 96.
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3700-7. PubMed ID: 19723755
    [Abstract] [Full Text] [Related]

  • 11. Radioiodine and the immune system.
    DeGroot LJ.
    Thyroid; 1997 Apr; 7(2):259-64. PubMed ID: 9133697
    [Abstract] [Full Text] [Related]

  • 12. Does radioiodine cause the ophthalmopathy of Graves' disease?
    McDougall IR.
    Nucl Med Commun; 1993 Feb; 14(2):79-81. PubMed ID: 8429998
    [No Abstract] [Full Text] [Related]

  • 13. The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole.
    Kung AW, Yau CC, Cheng A.
    J Clin Endocrinol Metab; 1994 Aug; 79(2):542-6. PubMed ID: 7913934
    [Abstract] [Full Text] [Related]

  • 14. Radioiodine treatment, ablation, and ophthalmopathy: a balanced perspective.
    Tallstedt L, Lundell G.
    Thyroid; 1997 Apr; 7(2):241-5. PubMed ID: 9133694
    [Abstract] [Full Text] [Related]

  • 15. Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
    Chen DY, Schneider PF, Zhang XS, Luo XY, He ZM, Chen TH.
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):1-6. PubMed ID: 24203649
    [Abstract] [Full Text] [Related]

  • 16. Post-radioiodine De Novo Onset Graves' Ophthalmopathy: Case Reports and a Review of the Literature.
    Batra R, Krishnasamy SK, Buch H, Sandramouli S.
    Semin Ophthalmol; 2015 May; 30(3):227-31. PubMed ID: 24409943
    [Abstract] [Full Text] [Related]

  • 17. Chronology of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, Gorman CA.
    Am J Ophthalmol; 1996 Apr; 121(4):426-34. PubMed ID: 8604736
    [Abstract] [Full Text] [Related]

  • 18. Endocrine ophthalmopathy and radioiodine therapy.
    Karlsson FA.
    Acta Oncol; 2006 Apr; 45(8):1046-50. PubMed ID: 17118837
    [Abstract] [Full Text] [Related]

  • 19. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy.
    Perros P, Kendall-Taylor P, Neoh C, Frewin S, Dickinson J.
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5321-3. PubMed ID: 15985483
    [Abstract] [Full Text] [Related]

  • 20. Radioiodine therapy versus antithyroid medications for Graves' disease.
    Ma C, Xie J, Wang H, Li J, Chen S.
    Cochrane Database Syst Rev; 2016 Feb 18; 2(2):CD010094. PubMed ID: 26891370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.